Novartis Investigative Site

Shibukawa, Gunma 377-8511

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Primary Immune Thrombocytopenia (ITP)

Studies at this site

• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma — Completed